{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T15:10:22Z","timestamp":1740669022328,"version":"3.38.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.msard.2025.106259","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T06:44:59Z","timestamp":1736059499000},"page":"106259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of siponimod on retinal thickness, a marker of neurodegeneration, in participants with SPMS: Findings from the EXPAND OCT substudy"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0997-8817","authenticated-orcid":false,"given":"Patrick","family":"Vermersch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Bar-Or","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A.C.","family":"Cree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Giovannoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Catherine","family":"Mousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Maio-Twofoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Kappos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106259_bib0001","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.msard.2018.03.007","article-title":"Optical coherence tomography as a biomarker of neurodegeneration in multiple sclerosis: a review","volume":"22","author":"Alonso","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"10.1016\/j.msard.2025.106259_bib0002","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00415-016-8127-y","article-title":"Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study","volume":"263","author":"Balk","year":"2016","journal-title":"J Neurol"},{"issue":"1\u20132","key":"10.1016\/j.msard.2025.106259_bib0003","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2014.06.031","article-title":"Physiological variation of retinal layer thickness is not caused by hydration: a randomised trial","volume":"344","author":"Balk","year":"2014","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.msard.2025.106259_bib0004","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1167\/iovs.11-8209","article-title":"The physiological variation of the retinal nerve fiber layer thickness and macular volume in humans as assessed by spectral domain-optical coherence tomography","volume":"53","author":"Balk","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.msard.2025.106259_bib0005","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1177\/13524585221083194","article-title":"Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: analysis of EXPAND core and extension data up to >5\u2009years","volume":"28","author":"Cree","year":"2022","journal-title":"Mult Scler"},{"issue":"24","key":"10.1016\/j.msard.2025.106259_bib0006","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1212\/WNL.0000000000002774","article-title":"The APOSTEL recommendations for reporting quantitative optical coherence tomography studies","volume":"86","author":"Cruz-Herranz","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.msard.2025.106259_bib0007","doi-asserted-by":"crossref","first-page":"e1014","DOI":"10.1212\/WNL.0000000000207551","article-title":"Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: post Hoc Analyses of the SPRINT-MS Trial","volume":"101","author":"Ehrhardt","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2025.106259_bib0008","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12883-018-1065-9","article-title":"A cross-sectional and longitudinal study evaluating brain volumes, RNFL, and cognitive functions in MS patients and healthy controls","volume":"18","author":"Frau","year":"2018","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.msard.2025.106259_bib0009","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.24351","article-title":"Dynamics of retinal injury after acute optic neuritis","volume":"77","author":"Gabilondo","year":"2015","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.msard.2025.106259_bib0010","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1111\/j.1755-3768.2010.02045.x","article-title":"Intra and interoperator reproducibility of retinal nerve fibre and macular thickness measurements using Cirrus Fourier-domain OCT","volume":"89","author":"Garcia-Martin","year":"2011","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"10.1016\/j.msard.2025.106259_bib0011","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.oftal.2010.08.004","article-title":"Effect of treatment in loss of retinal nerve fibre layer in multiple sclerosis patients]","volume":"85","author":"Garc\u00eda-Mart\u00edn","year":"2010","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"16","key":"10.1016\/j.msard.2025.106259_bib0012","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000295995.46586.ae","article-title":"Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis","volume":"69","author":"Gordon-Lipkin","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2025.106259_bib0013","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1055\/s-0039-1700528","article-title":"Optical Coherence Tomography in Multiple Sclerosis","volume":"39","author":"Graves","year":"2019","journal-title":"Semin Neurol"},{"issue":"6","key":"10.1016\/j.msard.2025.106259_bib0014","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/brain\/awq080","article-title":"Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration","volume":"133","author":"Green","year":"2010","journal-title":"Brain"},{"issue":"10127","key":"10.1016\/j.msard.2025.106259_bib0015","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","article-title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2025.106259_bib0016","first-page":"1007","article-title":"Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography","volume":"4","author":"Khanifar","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.msard.2025.106259_bib0017","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fneur.2020.00450","article-title":"Visualizing the Central Nervous System: imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders","volume":"11","author":"Kuchling","year":"2020","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.msard.2025.106259_bib0018","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/1352458519872751","article-title":"Optical coherence tomography and multiple sclerosis: update on clinical application and role in clinical trials","volume":"26","author":"Lambe","year":"2020","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.msard.2025.106259_bib0019","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S1474-4422(16)00068-5","article-title":"Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study","volume":"15","author":"Martinez-Lapiscina","year":"2016","journal-title":"The Lancet Neurol."},{"issue":"10","key":"10.1016\/j.msard.2025.106259_bib0020","doi-asserted-by":"crossref","first-page":"e2302","DOI":"10.1002\/brb3.2302","article-title":"Optical coherence tomography monitoring and diagnosing retinal changes in multiple sclerosis","volume":"11","author":"Mehmood","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/j.msard.2025.106259_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120847","article-title":"Optical coherence tomography (OCT) measurements and disability in multiple sclerosis (MS): a systematic review and meta-analysis","volume":"454","author":"Mirmosayyeb","year":"2023","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.msard.2025.106259_bib0022","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14737175.2019.1559051","article-title":"Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis","volume":"19","author":"Oertel","year":"2019","journal-title":"Expert Rev Neurother"},{"issue":"11","key":"10.1016\/j.msard.2025.106259_bib0023","first-page":"2520","article-title":"Correlation between morphological and functional retinal impairment in multiple sclerosis patients","volume":"40","author":"Parisi","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.msard.2025.106259_bib0024","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/acn3.51473","article-title":"Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study","volume":"8","author":"Paul","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"10.1016\/j.msard.2025.106259_bib0025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"The Lancet Neurol."},{"issue":"11","key":"10.1016\/j.msard.2025.106259_bib0026","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s10072-020-04431-4","article-title":"Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study","volume":"41","author":"Pietroboni","year":"2020","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.msard.2025.106259_bib0027","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.24487","article-title":"Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study","volume":"78","author":"Saidha","year":"2015","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.msard.2025.106259_bib0028","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1177\/1352458511418630","article-title":"Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness","volume":"17","author":"Saidha","year":"2011","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.msard.2025.106259_bib0029","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1352458514538110","article-title":"Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria","volume":"21","author":"Schippling","year":"2015","journal-title":"Mult Scler"},{"issue":"10","key":"10.1016\/j.msard.2025.106259_bib0030","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00415-008-0985-5","article-title":"Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy","volume":"255","author":"Siger","year":"2008","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.msard.2025.106259_bib0031","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s00415-022-11474-4","article-title":"Optical coherence tomography as a prognostic tool for disability progression in MS: a systematic review","volume":"270","author":"Swinnen","year":"2023","journal-title":"J Neurol"},{"issue":"11","key":"10.1016\/j.msard.2025.106259_bib0032","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/ene.14421","article-title":"Optical coherence tomography measures correlate with brain and spinal cord atrophy and multiple sclerosis disease-related disability","volume":"27","author":"Vidal-Jordana","year":"2020","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.msard.2025.106259_bib0033","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1352458517739136","article-title":"Longitudinal optical coherence tomography study of optic atrophy in secondary progressive multiple sclerosis: results from a clinical trial cohort","volume":"25","author":"Winges","year":"2019","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2025.106259_bib0034","unstructured":"World Medical Association, 2024. Declaration of Helsinki - Ethical Principles For Medical Research Involving Human Subjects. Ferney-Voltaire: Author. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/. Accessed 06 January 2025."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T14:16:16Z","timestamp":1740665776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":34,"alternative-id":["S2211034825000033"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106259","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of siponimod on retinal thickness, a marker of neurodegeneration, in participants with SPMS: Findings from the EXPAND OCT substudy","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106259"}}